Westside Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $393K | Sell |
|
|||||
|
2025
Q2 | $340K | Sell |
|
|||||
|
2025
Q1 | $269K | Buy |
|
|||||
|
2024
Q4 | $242K | Sell |
|
|||||
|
2024
Q3 | $308K | Sell |
|
|||||
|
2024
Q2 | $403K | Buy |
|
|||||
|
2024
Q1 | $504K | Buy |
|
|||||
|
2023
Q4 | $442K | Buy |
|
|||||
|
2023
Q3 | $318K | Hold |
|
|||||
|
2023
Q2 | $394K | Sell |
|
|||||
|
2023
Q1 | $322K | Sell |
|
|||||
|
2022
Q4 | $27.3K | Hold |
|
|||||
|
2022
Q3 | $43.6K | Hold |
|
|||||
|
2022
Q2 | $44.1K | Sell |
|
|||||
|
2022
Q1 | $44.1K | Buy |
|
|||||
|
2021
Q4 | $44K | Buy |
|
|||||
|
2021
Q3 | $43.8K | Buy |
|
|||||
|
2021
Q2 | $39.3K | Buy |
|
|||||
|
2021
Q1 | $29.6K | Buy |
|
|||||
|
2020
Q4 | $30.6K | Sell |
|
|||||
|
2020
Q3 | $25.1K | Sell |
|
|||||
|
2020
Q2 | $22.1K | Sell |
|
|||||
|
2020
Q1 | $25.5K | Buy |
|
|||||
|
2019
Q2 | $4 | Buy |
|
|||||
|
2018
Q4 | $2.86K | Hold |
|
|||||
|
2018
Q3 | $4.23K | Hold |
|
|||||
|
2018
Q2 | $6K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $2.61K | Hold |
|
|||||
|
2017
Q3 | $1.97K | Hold |
|
|||||
|
2017
Q2 | $1.6K | Hold |
|
|||||
|
2017
Q1 | $1.99K | Buy |
|